| 摘要 |
The present invention relates to method, device and kit for determining a condition related to dysfunction of the RPT in a subject comprising detecting the presence of type III Carbonic Anhydrase, CA-III, in a urine sample of said subject. It also relates to a method for monitoring the progress of a condition, and for determining the efficacy of a treatment.
|
